Cover Image

Editorial: Pulmonary fibrosis: One manifestation, various diseases

Saved in:

Bibliographic Details
Main Authors:	Barbara Ruaro (Author), Marco Matucci Cerinic (Author), Francesco Salton (Author), Elisa Baratella (Author), Marco Confalonieri (Author), Michael Hughes (Author)
Format:	Book
Published:	Frontiers Media S.A., 2022-10-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Gastroesophageal Reflux Disease in Idiopathic Pulmonary Fibrosis: Viewer or Actor? To Treat or Not to Treat?
by: Barbara Ruaro, et al.
Published: (2022)

The Relationship between Pulmonary Damage and Peripheral Vascular Manifestations in Systemic Sclerosis Patients
by: Barbara Ruaro, et al.
Published: (2021)

The Treatment of Lung Involvement in Systemic Sclerosis
by: Barbara Ruaro, et al.
Published: (2021)

Nintedanib in Idiopathic Pulmonary Fibrosis: Tolerability and Safety in a Real Life Experience in a Single Centre in Patients also Treated with Oral Anticoagulant Therapy
by: Barbara Ruaro, et al.
Published: (2023)

Safety of Nintedanib in a Patient with Chronic Pulmonary Fibrosis and Kidney Disease
by: Marta Maggisano, et al.
Published: (2024)

Pirfenidone and Nintedanib in Pulmonary Fibrosis: Lights and Shadows
by: Maria Chianese, et al.
Published: (2024)

Functional Progression after Dose Suspension or Discontinuation of Nintedanib in Idiopathic Pulmonary Fibrosis: A Real-Life Multicentre Study
by: Barbara Ruaro, et al.
Published: (2024)

Gastrointestinal Manifestations of Sarcoidosis: A State-of-the-Art, Comprehensive Review of the Literature-Practical Clinical Insights and Many Unmet Needs on Diagnosis and Treatment
by: Salvatore Nicolosi, et al.
Published: (2024)

Special Issue "Rheumatic Diseases: Pathophysiology, Targeted Therapy, Focus on Vascular and Pulmonary Manifestations 2022"
by: Barbara Ruaro, et al.
Published: (2023)

Pirfenidone in Idiopathic Pulmonary Fibrosis: Real-World Observation on Efficacy and Safety, Focus on Patients Undergoing Antithrombotic and Anticoagulant
by: Nicolò Reccardini, et al.
Published: (2024)

Leptin Levels in Various Manifestations of Pulmonary Tuberculosis
by: Hakan Buyukoglan, et al.
Published: (2007)

Editorial: Evolution in respiratory pharmacology
by: Barbara Ruaro, et al.
Published: (2023)

Theory and Practice of Glucocorticoids in COVID-19: Getting to the Heart of the Matter-A Critical Review and Viewpoints
by: Francesco Salton, et al.
Published: (2023)

Is telemedicine a golden opportunity or a dangerous roundabout for chronic rheumatic diseases? A narrative review
by: Maria Ramona Melis, et al.
Published: (2022)

Editorial: Applications of medicine in treating pulmonary fibrosis
by: Wenjun Li, et al.
Published: (2023)

Vasculogenesis and angiogenesis: vascular damage in systemic sclerosis
by: M. Matucci Cerinic, et al.
Published: (2011)

Menstruation-Related Disorders-Dysmenorrhea and Heavy Bleeding-as Significant Epiphenomena in Women With Rheumatic Diseases
by: Martina Orlandi, et al.
Published: (2022)

Rheumatologic rehabilitation: the great expectation for rheumatic patients
by: M. Matucci Cerinic, et al.
Published: (2012)

Critical finger ischemia and myocardial fibrosis development after sudden interruption of sildenafil treatment in a systemic sclerosis patient
by: C. Bruni, et al.
Published: (2016)

Pharmaceuticals in treatment of oral mucosal manifestations of manifestations of various diseases on the oral mucosa
by: Irina K. Lutskaya
Published: (2021)

Pulmonary Fibrosis
Published: (2019)

ORAL MANIFESTATIONS IN PATIENTS WITH CYSTIC FIBROSIS
by: Mădălina Andreea Donos, et al.
Published: (2022)

COVID-19: Pulmonary and Extra Pulmonary Manifestations
by: Islam H. Elrobaa, et al.
Published: (2021)

Clinical manifestations of pulmonary and extra-pulmonary tuberculosis
by: Robert L. Serafino Wani
Published: (2013)

Adenosine and hyaluronan promote lung fibrosis and pulmonary hypertension in combined pulmonary fibrosis and emphysema
by: Scott D. Collum, et al.
Published: (2019)

Systemic Corticosteroid Administration in Coronavirus Disease 2019 Outcomes: An Umbrella Meta-Analysis Incorporating Both Mild and Pulmonary Fibrosis-Manifested Severe Disease
by: Bin Cheng, et al.
Published: (2021)

Idiopathic Pulmonary Fibrosis
Published: (2022)

Transthoracic ultrasound versus intraoperative ultrasound in patients with pulmonary fibrosis: Reappraisal of artifacts
by: Marco Sperandeo, et al.
Published: (2019)

Pulmonary Manifestation of Neuroblastoma in Children
by: S.M. Maksimova, et al.
Published: (2013)

Management of Pulmonary Hypertension in Idiopathic Pulmonary Fibrosis
by: Abdullah Rashed Alharbi
Published: (2024)

Rheumatologic rehabilitation: towards recommendations
by: S. Maddali Bongi, et al.
Published: (2014)

TRAIL-Dependent Resolution of Pulmonary Fibrosis
by: David M. Habiel, et al.
Published: (2018)

A study of Pulmonary Manifestations in Collagen Vascular Diseases
by: Parul Vadgama, et al.
Published: (2018)

Pulmonary manifestations in a group of patients with Behçet's disease
by: Sherif M Naguib, et al.
Published: (2015)

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
by: Wencheng Yu, et al.
Published: (2017)

Metabolic reprogramming of pulmonary fibrosis
by: Jiaxin Li, et al.
Published: (2022)

Cough in Idiopathic Pulmonary Fibrosis
by: Jennifer Mann, et al.
Published: (2021)

Elastase-Activated Antimicrobial Peptide for a Safer Pulmonary Treatment of Cystic Fibrosis Infections
by: Margherita Degasperi, et al.
Published: (2022)

Unusual manifestations of pleuro-pulmonary hydatidosis
by: Pradeep Vaideeswar, et al.
Published: (2012)

Heterogeneity in Fibroblast Proliferation and Survival in Idiopathic Pulmonary Fibrosis
by: David Michael Habiel, et al.
Published: (2014)